We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$263M
AUM Growth
-$29.3M
Cap. Flow
-$29M
Cap. Flow %
-11.04%
Top 10 Hldgs %
30.3%
Holding
117
New
10
Increased
6
Reduced
44
Closed
15

Top Sells

Rank Stock Value
1
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$14.7M
2
V icon
Visa
V
+$4.9M
3
C icon
Citigroup
C
+$4.48M
4
BIIB icon
Biogen
BIIB
+$4.1M
5
ARWR icon
Arrowhead Research
ARWR
+$4.09M

Sector Composition

Rank Sector Weight
1 Energy 18.46%
2 Communication Services 18.44%
3 Healthcare 15.65%
4 Industrials 11.15%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
26
Canadian National Railway
CNI
$76.2B
$3.9M 1.49%
69,440
-400
-0.6% -$22K
FWONA icon
27
Liberty Media Series A
FWONA
$23.4B
$3.9M 1.48%
167,850
-27,509
-14% -$657K
EOG icon
28
EOG Resources
EOG
$75.2B
$3.86M 1.47%
39,314
-19,050
-33% -$1.7M
TYPE
29
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.75M 1.43%
124,365
-300
-0.2% -$9.01K
BAY
30
DELISTED
BAYER AG SPONS ADR
BAY
$3.71M 1.41%
27,409
-144
-0.5% -$19.5K
T icon
31
AT&T
T
$178B
$3.66M 1.39%
138,137
+483
+0.4% +$12.1K
UBA
32
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.65M 1.39%
176,549
-4,200
-2% -$81.2K
PM icon
33
Philip Morris
PM
$299B
$3.55M 1.35%
43,325
-230
-0.5% -$18.6K
APL
34
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
$3.44M 1.31%
107,274
-1,350
-1% -$43.6K
SNY icon
35
Sanofi
SNY
$107B
$3.22M 1.23%
61,620
-2,455
-4% -$124K
CVX icon
36
Chevron
CVX
$396B
$3.21M 1.22%
27,010
-240
-0.9% -$27.9K
ESV
37
DELISTED
Ensco Rowan plc
ESV
$3.06M 1.17%
14,501
-482
-3% -$101K
KO icon
38
Coca-Cola
KO
$386B
$3.04M 1.16%
78,631
-1,200
-2% -$46.4K
LMT icon
39
Lockheed Martin
LMT
$130B
$2.9M 1.1%
17,738
-205
-1% -$32.2K
STML
40
DELISTED
Stemline Therapeutics, Inc.
STML
$2.69M 1.02%
+132,000
New +$3.2M
CVI icon
41
CVR Energy
CVI
$4.2B
$2.58M 0.98%
+61,000
New +$2.42M
CMCSA icon
42
Comcast
CMCSA
$96B
$2.51M 0.95%
100,200
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.19T
$2.45M 0.93%
88,370
-55,808
-39% -$1.62M
ALL icon
44
Allstate
ALL
$65.9B
$2.38M 0.91%
+42,160
New +$2.26M
VOD icon
45
Vodafone
VOD
$37.1B
$2.36M 0.9%
64,201
-50,901
-44% -$1.96M
GILD icon
46
Gilead Sciences
GILD
$181B
$2.35M 0.9%
33,194
-13,700
-29% -$1.07M
MON
47
DELISTED
Monsanto Co
MON
$2.33M 0.88%
20,435
-13,050
-39% -$1.45M
ABBV icon
48
AbbVie
ABBV
$451B
$2.1M 0.8%
40,800
-100
-0.2% -$5.05K
MOS icon
49
The Mosaic Company
MOS
$7.5B
$2M 0.76%
40,019
-1,035
-3% -$49.3K
DVY icon
50
iShares Select Dividend ETF
DVY
$23.8B
$1.92M 0.73%
26,175

Similar funds

Private Capital Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Private Capital Advisors held 117 positions worth $263M, down 10% from $292M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Private Capital Advisors withdrew a net $29M in Q1 2014, closing 15 positions and reducing 44 holdings. Its most notable exit was SANGAMO THERAPEUTICS INC, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Private Capital Advisors opened a new position in SiriusXM worth $4.01M.

  • Private Capital Advisors's largest Q1 2014 buy was SiriusXM: 125,230 shares worth $4.01M.
  • Private Capital Advisors added most to Liberty Global Class C in Q1 2014, an estimated $2.05M increase.
  • Private Capital Advisors's biggest Q1 2014 reduction was Apple, cutting an estimated $2.93M.
  • Private Capital Advisors fully exited SANGAMO THERAPEUTICS INC in Q1 2014, selling an estimated $14.7M.
  • Private Capital Advisors's ten largest holdings make up 30% of its $263M portfolio in Q1 2014.
  • Private Capital Advisors opened 10 new positions and closed 15 in Q1 2014.
  • Private Capital Advisors's portfolio value fell 10% quarter-over-quarter to $263M.

Based on Private Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.